Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma.
Kasamon YL, Jacene HA, Gocke CD, Swinnen LJ, Gladstone DE, Perkins B, Link BK, Popplewell LL, Habermann TM, Herman JM, Matsui WH, Jones RJ, Ambinder RF.
Kasamon YL, et al. Among authors: jacene ha.
Blood. 2012 May 3;119(18):4129-32. doi: 10.1182/blood-2012-01-402792. Epub 2012 Feb 16.
Blood. 2012.
PMID: 22343727
Free PMC article.
Clinical Trial.